[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fxLN3MUwXCdr5RPjwZYIDpOj8CHyjOmngWTgoKXPtZbg":3,"$fTbF66wD9VySIkSaF9yJemW176oAkoGSrZi0h5KXYlks":32,"$f3Ft0rKFJHppdzE-vuveecxx1BUcg9iOlMLtyzf_MJDg":253},[4,8,12,16,20,24,28],{"title":5,"slug":6,"path":7},"About Microbeonline.com","about-microbeonline-com","\u002Fabout-microbeonline-com\u002F",{"title":9,"slug":10,"path":11},"About Me","about-me","\u002Fabout-microbeonline-com\u002Fabout-me\u002F",{"title":13,"slug":14,"path":15},"Advertise with Us","advertise-us","\u002Fadvertise-us\u002F",{"title":17,"slug":18,"path":19},"Privacy Policy","privacy-policy","\u002Fprivacy-policy\u002F",{"title":21,"slug":22,"path":23},"Abbreviations","abbreviations","\u002Fabbreviations\u002F",{"title":25,"slug":26,"path":27},"Microbes","microbes","\u002Fmicrobes\u002F",{"title":29,"slug":30,"path":31},"Books","recommended-books","\u002Frecommended-books\u002F",{"type":33,"data":34},"blog",{"slug":35,"title":36,"description":37,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":40,"lastUpdatedDate":41,"draft":42,"category":43,"image":38,"body":44,"faq":45,"tags":64,"related":66},"antigens-in-disease-diagnosis","Antigen Detection Tests for Disease Diagnosis: Methods, Examples, and Clinical Uses","Antigen detection tests identify pathogen proteins directly in blood, urine, stool, or CSF before antibodies appear. Learn the methods (ELISA, RDT, immunofluorescence, latex agglutination), key antigens (NS1, HBsAg, p24, HRP2, Cryptococcal), and when antigen testing beats serology.",null,"Acharya Tankeshwar","2019-10-22","2026-07-19",false,"immunology","A 32-year-old man presents on day 2 of fever, severe headache, and neck stiffness. CSF is collected by lumbar puncture. A Gram stain shows no organisms. Culture will take 48–72 hours. The patient is critically ill and cannot wait.\n\nIn the laboratory, a latex agglutination test for capsular polysaccharide antigens is performed on the CSF in 15 minutes and returns positive for *Cryptococcus neoformans*. Antifungal treatment begins immediately. The culture confirms *Cryptococcus* three days later.\n\nThis case captures the defining advantage of antigen detection: it identifies the pathogen directly, without waiting for the immune system to respond. In early infection, in immunocompromised patients who cannot mount adequate antibody responses, and in any situation requiring a same-visit result, antigen detection frequently provides diagnostic answers that antibody-based serology cannot.\n\n> **This article and its companion:** This article covers **antigen detection** — identifying pathogen components directly in clinical specimens. For **antibody-based serological tests** (ELISA, RPR, TPHA, Widal, ASO, Monospot, and more), see the companion article: [Serological Tests for Disease Diagnosis](\u002Fantibodies-disease-diagnosis\u002F).\n>\n> Together these two articles cover the full spectrum of immunodiagnostic testing. The fundamental difference: antigen tests ask *\"Is the pathogen here right now?\"*; antibody tests ask *\"Has the body responded to this pathogen?\"*\n\nDetection of specific antigens in a sample (blood, urine, CSF, or stool) using immunologic methods; precipitin tests, particle agglutination, immunofluorescence, immunochromatography, or enzyme immunoassay **is** the mainstay of rapid infection diagnosis. These test methods use polyclonal and monoclonal antibodies to detect specific antigens of the pathogen of interest.\n\n> Antigens are foreign substances, usually high molecular weight proteins or glycoproteins, that elicit the production of antibodies. One organism may contain different antigens that the host will recognize as foreign.\n\n## Why Antigen Detection? The Clinical Case\n\nIn any infection, **antigen precedes antibody**. The pathogen (or its proteins) enters the host before the immune system has time to generate a detectable antibody response. This creates a window period during which antibody tests are negative even though infection is present.\n\nAntigen detection closes this window. It also solves three other diagnostic challenges that antibody testing cannot:\n\n| Clinical situation | Why antibody testing fails | Why antigen testing works |\n| --- | --- | --- |\n| **Early acute infection** (days 1–7) | Antibodies not yet detectable (window period) | Pathogen antigens are present and detectable immediately |\n| **Immunocompromised patients** (HIV, transplant, chemotherapy) | Cannot mount adequate antibody response; serology unreliable | Detects pathogen directly regardless of immune status |\n| **Point-of-care \u002F rapid diagnosis needed** | ELISA and treponemal tests take hours to days | Lateral flow RDTs give results in 15–20 minutes |\n| **Monitoring active infection** | IgG persists for life — cannot distinguish active from past | Antigen clearance with treatment confirms therapeutic response |\n\n**The practical rule:** Use antigen detection first when the patient is acutely ill and early in the illness. Switch to or add antibody detection when the clinical picture is subacute, retrospective, or when immunity status is the question (post-vaccination, epidemiology).\n\n## Methods Used in Antigen Detection\n\nThe following methods are used to detect pathogen antigens in clinical specimens. Each has different sensitivity, specificity, speed, and infrastructure requirements:\n\n| Method | Principle | Speed | Setting | Examples |\n| --- | --- | --- | --- | --- |\n| **Lateral flow \u002F RDT (Rapid Diagnostic Test)** | Antigen binds antibody-labelled particles; migrates along membrane; colour line appears | 10–20 minutes | Point-of-care, field, district laboratory | Malaria RDT, dengue NS1, HIV combo, COVID-19 Ag, Strep A |\n| **ELISA (EIA)** | Antigen captured by antibody on plate; detected by enzyme-labelled second antibody; colour reaction | 2–4 hours | Laboratory | HBsAg, HBeAg, HIV p24, dengue NS1, H. pylori stool antigen |\n| **Latex agglutination** | Antigen agglutinates antibody-coated latex beads — visible clumping | 15–30 minutes | Laboratory | Cryptococcal antigen (CSF\u002Fserum), meningococcal polysaccharide, Strep A, GBS |\n| **Immunofluorescence (DFA)** | Fluorescent-labelled antibody applied directly to specimen; organism glows under fluorescence microscope | 1–2 hours | Reference laboratory | Legionella, Bordetella pertussis, HSV, RSV, Giardia |\n| **Co-agglutination** | Antibody bound to Protein A of *S. aureus* Cowan I strain; antigen causes agglutination | 15–30 minutes | Laboratory | Lancefield group identification, Neisseria |\n| **Immunochromatography (ICT)** | Antibody-labelled coloured particles; lateral flow format | 10–20 minutes | Point-of-care | Malaria, dengue, filariasis |\n| **Ouchterlony double diffusion** | Antigen and antibody diffuse toward each other in agar; precipitin line at equivalence | 24–48 hours | Reference laboratory | Exoantigen confirmation of systemic fungi (Histoplasma, Blastomyces, Coccidioides) |\n\n![ - Blood sample and lab request for anti-HIV testing](https:\u002F\u002Fassets.microbeonline.com\u002Fblogs\u002FBlood-and-HIV-Testing.jpg)Figure: Blood sample and lab request for anti-HIV testing\n\n### Stool Antigen Test\n\nStool antigen tests (SATs) are noninvasive diagnostic tools for *Helicobacter pylori* infection, introduced after the urea breath test (UBT). This test was introduced after [urea breath test (UBT)](\u002Furea-breath-test-ubt-h-pylori-principle-procedure-results\u002F). The currently used stool antigen test for diagnosing H. pylori infection is based on enzyme immunoassay (EIA) or immunochromatography (ICA).\n\nStool antigen test (SAT) is recommended by WHO for both initial diagnosis and test-of-cure after *H. pylori* eradication therapy. For test-of-cure, SAT should be performed ≥4 weeks after completing antibiotic treatment. Serology (anti-H. pylori IgG) is not suitable for test-of-cure because IgG remains elevated for months to years after successful eradication.\n\n### Urine Antigen Test\n\nUrinary antigen testing has grown in popularity for several significant respiratory infections, particularly *Legionella pneumophila* (legionellosis), *Streptococcus pneumoniae* (pneumococcal pneumonia), and *Histoplasma capsulatum* (histoplasmosis). Though these organisms generally cannot be cultured from urine, antigens shed by them are concentrated in the kidney and excreted in urine. Soluble antigens from *Streptococcus agalactiae* and *Haemophilus influenzae* may concentrate in urine.\n\nUrine antigens are then detected via an immunoassay such as an [enzyme-linked immunosorbent assay (ELISA)](https:\u002F\u002Fmicrobeonline.com\u002Felisa-principle-types-and-applications\u002F) or an immunochromatographic or lateral flow assay (LFA).\n\n**When urine antigen testing changes clinical management:** The Legionella urinary antigen test (UAT) detects Legionella serogroup 1 responsible for \\~80% of Legionnaires' disease within 3 hours. It allows targeted antibiotic therapy (levofloxacin or azithromycin instead of broad-spectrum) at a stage when culture results are not yet available. Similarly, the pneumococcal UAT can guide de-escalation from broad-spectrum coverage in severe community-acquired pneumonia within the first 24 hours.\n\n### Antigens present in Cerebrospinal fluid (CSF)\n\nSoluble capsular polysaccharide antigens produced by the most common bacterial agents of meningitis including *Streptococcus pneumoniae*, *Neisseria meningitidis*, *Haemophilus influenzae* type b, and group B *Streptococcus* can be detected in CSF using latex agglutination, coagglutination, or commercial agglutination systems.\n\n**Cryptococcal antigen- the clinical priority:** Cryptococcal meningitis is the most common cause of meningitis in HIV-positive adults in sub-Saharan Africa, responsible for 15–20% of AIDS-related deaths. WHO recommends Cryptococcal antigen (CrAg) lateral flow assay screening in all HIV-positive patients with CD4 <100 cells\u002FµL before they develop symptoms. The CrAg LFA is >99% sensitive and specific, costs less than $5, and requires no laboratory equipment. Early detection at the asymptomatic stage dramatically reduces mortality.\n\n### Antigen testing in other samples\n\n- Detection of group A beta-hemolytic antigen from throat swabs\n- Detection of group B streptococcal antigen in vaginal secretions\n\n## Commonly Tested Antigens in Disease Diagnosis\n\n| Antigen | Disease | Specimen | Test method | Clinical significance |\n| --- | --- | --- | --- | --- |\n| **p24** | HIV infection | Blood | ELISA; 4th-gen combo Ag\u002FAb test | Detectable 14–20 days post-infection — before anti-HIV antibodies appear; used in window period; neonatal diagnosis |\n| **HBsAg** (Australia antigen) | Hepatitis B | Blood | ELISA; RDT | Presence = current HBV infection (acute or chronic); first serological marker to appear |\n| **HBeAg** | Hepatitis B | Blood | ELISA | Indicates active viral replication and high infectivity |\n| **NS1 antigen** | Dengue | Blood | ELISA; RDT | Detectable days 1–7 of illness — earlier than IgM; loses sensitivity after day 7; does not provide serotype |\n| **HRP2** (Histidine-rich protein 2) | Falciparum malaria | Blood | RDT | Expressed only by *P. falciparum*; most common malaria RDT target; may persist after parasite clearance (false positive) |\n| **pLDH** (Parasite lactate dehydrogenase) | All malaria species | Blood | RDT | Detects all four *Plasmodium* species; clears within 24–48 hrs of treatment — better for test-of-cure than HRP2 |\n| **Aldolase** | All malaria species | Blood | RDT (pan-malarial) | Pan-species marker; used alongside HRP2 and pLDH in combination RDTs |\n| **Cryptococcal polysaccharide antigen** | Cryptococcal meningitis | CSF; serum | Latex agglutination; lateral flow assay | >99% sensitivity\u002Fspecificity; critical for early diagnosis in HIV patients; CSF preferred |\n| **Pneumococcal polysaccharide** | Pneumococcal pneumonia; meningitis | Urine; CSF | ICT; latex agglutination | Urine UAT: sensitivity 70–80% for pneumococcal pneumonia; remains positive days after treatment starts |\n| **Legionella serogroup 1 antigen** | Legionnaires' disease | Urine | ICT; ELISA | 70–90% sensitivity; only detects serogroup 1 (\\~80% of cases); remains positive weeks after treatment |\n| **Histoplasma antigen** | Histoplasmosis | Urine; BAL | EIA | Most sensitive test in disseminated histoplasmosis; essential in immunocompromised patients |\n| **H. pylori antigens** | H. pylori gastritis\u002Fpeptic ulcer | Stool | EIA; ICT | Preferred over serology for diagnosis and test-of-cure; positive result indicates active infection |\n| **Group A Streptococcal antigen** | Strep throat; scarlet fever | Throat swab | Lateral flow RDT | Results in 5–10 minutes; negative rapid test should be backed up by throat culture in children |\n| **Group B Streptococcal (GBS) antigen** | Neonatal GBS sepsis\u002Fmeningitis | Vaginal\u002Frectal; CSF; urine | Latex agglutination | Antenatal GBS screening guides intrapartum prophylaxis |\n| **Rotavirus antigen** | Viral gastroenteritis | Stool | EIA; lateral flow | Most common cause of severe diarrhoea in children under 5; rapid antigen test widely used |\n| **COVID-19 (SARS-CoV-2) antigen** | COVID-19 | Nasopharyngeal swab | Lateral flow RDT | High specificity (\\~99%); lower sensitivity than PCR especially in asymptomatic; most useful in symptomatic patients days 1–5 |\n\n**P24 Antigen**\n\np24 is a capsid structural protein that makes up a protein ‘shell’ on the surface of the HIV virus. p24 test is generally only positive from about two to three weeks after infection with HIV.\n\n**Histidine rich protein 2 (HRP2)**\n\nHRP-II is an abundant protein expressed only by *Plasmodium falciparum* and is the target for the most commonly used RDTs.\n\n**Parasite lactate dehydrogenase (pLDH)**\n\nIt is produced by the asexual and sexual stages (gametocytes) of malaria parasites. Malarial test kits that are currently available detect pLDH from all four species of Plasmodium. They can distinguish *P. falciparum* from the non-falciparum species, but cannot distinguish between *P. malariae, P. ovale*, and *P. vivax.*\n\n![ - Microbiologist standing at desk and holding test tube rack while preparing blood samples for centrifuge](https:\u002F\u002Fassets.microbeonline.com\u002Fblogs\u002FTesting-blood-sample.jpg)Figure: Microbiologist standing at desk and holding test tube rack while preparing blood samples for centrifuge\n\n**HBeAg**\n\nHBeAg is a hepatitis B viral protein. It is an indicator of active viral replication; this means the person infected with Hepatitis B can likely transmit the virus to another person (i.e. the person is infectious).\n\n**HBsAg (Australia antigen)**\n\nHBsAg is the surface antigen of the hepatitis B virus (HBV). It indicates the current hepatitis B infection.\n\n**NS1 Antigen**\n\nNS1 tests detect the non-structural protein NS1 of [dengue virus](\u002Flaboratory-diagnosis-of-dengue-viral-infection\u002F) in the serum using synthetically labeled antibodies. NS1 is detectable during the acute phase of dengue virus infections.\n\nNS1 tests can be as sensitive as molecular tests during the first 0-7 days of symptoms. After day 7, NS1 tests are not recommended. A positive NS1 test result is indicative of a dengue infection but does not provide serotype information.\n\n## How to Remember\n\n**Antigen = the pathogen's ID card; antibody = the body's response to seeing the ID card.** Antigen tests look for the ID card directly. Antibody tests look for proof the body has seen it. The ID card appears first — which is why antigen tests work earlier in infection.\n\n**The three specimen types and what they tell you:**\n\n| Specimen | What antigen testing finds | Classic example |\n| --- | --- | --- |\n| **Blood** | Systemic infection \u002F viraemia | HIV p24, dengue NS1, HBsAg, malaria RDT |\n| **Urine** | Antigens concentrated in kidney and excreted | Legionella UAT, Pneumococcal UAT, Histoplasma EIA |\n| **CSF** | CNS infection — organism in CSF or antigens shed into it | Cryptococcal CrAg, bacterial capsular antigens |\n| **Stool** | GI infection or organisms shed in faeces | H. pylori SAT, rotavirus, Giardia, Cryptosporidium |\n\n**The rapid test revolution in LMIC settings:** Malaria RDTs, dengue NS1 RDTs, HIV combo tests, Cryptococcal LFAs, and COVID-19 antigen tests all share one characteristic — they are lateral flow immunochromatographic tests that any trained health worker can perform in 15 minutes without laboratory equipment. These RDTs have transformed diagnostics in district hospitals and health posts where culture and ELISA are not available. Understanding the antigen each detects and its clinical window is the core knowledge for any healthcare worker in tropical settings.\n\n**The window period visual:**\n\n```\nDAY 0         DAY 3–5          DAY 7–14         WEEKS–MONTHS\n  |               |                |                  |\nInfection    ANTIGEN peaks    IgM appears        IgG persists\n              (detectable)    (seroconversion)   (for life)\n\nUse: ← Antigen tests here → ← IgM tests here → ← IgG tests here →\n```\n\nThe earlier the presentation, the more you need antigen detection. The later or more retrospective the diagnosis, the more antibody tests help.\n\n### Key exam facts in one table\n\n| Antigen | Disease | First detectable | Memory aid |\n| --- | --- | --- | --- |\n| p24 | HIV | 14–20 days post-infection, *before* antibodies | The capsid shows up to the party before the antibody guest list is even printed |\n| HBsAg | Hepatitis B | First marker to appear in acute infection | \"s\" for \"surface\" and \"s\" for \"seen first\" |\n| HBeAg | Hepatitis B | Present during active replication | Think \"e\" = \"excreting virus\" high infectivity |\n| NS1 | Dengue | Days 1–7, gone after day 7 | NS1 is a week-one-only guest; IgM\u002FIgG take over after it leaves |\n| HRP2 | *P. falciparum* malaria | Persists after cure (can false-positive) | HRP2 is the guest who overstays; bad for test-of-cure |\n| pLDH | All 4 *Plasmodium* species | Clears within 24–48 hrs of treatment | pLDH leaves on time, good for test-of-cure |\n| CrAg | Cryptococcal meningitis | Detectable even without antibody response | Works precisely when the immune system can't; screen CD4 <100 *before* symptoms |\n| Legionella UAT | Legionellosis | Within 3 hours; serogroup 1 only (\\~80% of cases) | Negative UAT ≠ ruled out it's blind to the other 20% |\n\n### References\n\n1. Tille, P. M. (2017). *Bailey and Scott's Diagnostic Microbiology* (14th ed.). Elsevier.\n2. World Health Organization. (2022). *Guidelines for the Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-infected Adults, Adolescents and Children.* Geneva: WHO.\n3. World Health Organization. (2015). *Guidelines for the Treatment of Malaria* (3rd ed.). Geneva: WHO. \\[Malaria RDT section\\]\n4. Huong, V. T. Q., et al. (2014). Urine antigen tests for the diagnosis of respiratory infections. *Clinics in Laboratory Medicine*, 34(2), 219–236.\n5. Leber, A. L. (Ed.). (2016). *Clinical Microbiology Procedures Handbook* (4th ed.). ASM Press.",[46,49,52,55,58,61],{"question":47,"answer":48},"Why is the dengue NS1 antigen test only useful in the first seven days of illness?","The NS1 (non-structural protein 1) antigen is produced and secreted at high concentrations by dengue virus-infected cells during active viral replication. During the first 1–7 days of dengue illness, viraemia is high and NS1 is detectable in blood at concentrations well above the detection limits of commercial RDTs and ELISA kits. After approximately day 7, viral replication decreases as the immune response mounts, and simultaneously, immune complexes between anti-NS1 antibodies and the NS1 protein form, removing free NS1 from circulation. The NS1 concentration in blood falls below the detection threshold of most assays by day 7–9. After this point, dengue serology (IgM and IgG) becomes the appropriate test. The practical implication is that a negative NS1 test after day 7 does not exclude dengue infection — the antigen has been cleared by the immune response even if the patient is still symptomatic. Conversely, NS1 testing is particularly valuable in the first few days of illness when IgM has not yet appeared and serology would also be negative.",{"question":50,"answer":51},"What is the clinical significance of Cryptococcal antigen detection in HIV-positive patients?","Cryptococcal meningitis caused by Cryptococcus neoformans is the most common cause of meningitis in HIV-positive adults in Sub-Saharan Africa and Southeast Asia, accounting for 15–20% of AIDS-related deaths globally. In patients with CD4 counts below 100 cells\u002FµL, C. neoformans can disseminate from a pulmonary focus to the CNS before causing obvious clinical symptoms. WHO recommends routine Cryptococcal antigen (CrAg) screening using the lateral flow assay (LFA) in all HIV-positive patients with CD4 \u003C100 cells\u002FµL, regardless of symptoms. The CrAg LFA has sensitivity and specificity both exceeding 99% for cryptococcal meningitis, costs under $5 per test, and requires no laboratory equipment or refrigeration. A positive CrAg screen in an asymptomatic patient triggers diagnostic lumbar puncture and early pre-emptive antifungal treatment with fluconazole — before the patient develops severe meningitis. Studies have demonstrated that systematic CrAg screening with pre-emptive treatment reduces 10-week mortality by approximately 28% compared to waiting for symptomatic presentation. This is one of the most clinically impactful applications of antigen detection in resource-limited settings.",{"question":53,"answer":54},"Why do malaria HRP2-based RDTs sometimes remain positive after the parasites have been cleared by treatment?","HRP2 (histidine-rich protein 2) is a protein secreted specifically by Plasmodium falciparum asexual and sexual stage parasites. Unlike pLDH (parasite lactate dehydrogenase), which is an enzyme expressed only during active metabolism and clears from the blood within 24–48 hours after parasite death, HRP2 is a secreted protein that accumulates in the bloodstream and is cleared much more slowly — over days to weeks — by normal protein degradation processes. After successful antimalarial treatment that kills all parasites, HRP2 levels decline gradually but may remain detectable by RDT for up to 4 weeks after clinical and parasitological cure. This persistence means that HRP2-based RDTs cannot be reliably used to confirm treatment response or diagnose re-infection within one month of a previous falciparum infection. For test-of-cure in clinical trials and treatment monitoring programmes, pLDH-based RDTs or blood film microscopy are preferred because they reflect current parasitaemia rather than residual antigen from a cleared infection.",{"question":56,"answer":57},"Why does antigen testing detect infection earlier than antibody testing?","Antigen is part of the pathogen itself and is present from the moment of infection; antibodies take days to weeks for the immune system to produce, creating a window period where only antigen tests are positive.",{"question":59,"answer":60},"Why is serology not used to confirm H. pylori eradication?","Anti-H. pylori IgG can remain elevated for months to years after successful treatment, so it cannot distinguish active from past infection. Stool antigen testing or the urea breath test is used instead.",{"question":62,"answer":63},"Does a negative Legionella urinary antigen test rule out Legionnaires' disease?","No. The test detects only serogroup 1, which accounts for roughly 80% of cases; the remaining 20% caused by other serogroups will test negative despite active infection.",[65],"immunoassays",[67,94,119,145,170,195,203,237],{"slug":68,"title":69,"description":70,"seoTitle":38,"seoDescription":38,"author":71,"createdDate":72,"lastUpdatedDate":73,"draft":42,"category":43,"image":38,"faq":74,"tags":93},"determination-of-blood-group","Blood Grouping (ABO and Rh): Forward vs Reverse Typing and How to Interpret","How ABO and Rh blood grouping works: forward (cell) versus reverse (serum) typing, why the two must agree, the Bombay phenotype trap, and how agglutination gives the result. Procedure and interpretation included.","Ashma Shrestha","2023-08-30","2026-07-20",[75,78,81,84,87,90],{"question":76,"answer":77},"What is the difference between forward and reverse blood grouping?","Forward (cell) grouping tests the patient's red cells with known anti-A and anti-B sera to find which antigens are present. Reverse (serum) grouping tests the patient's serum against known A and B cells to find which antibodies are present. The two must agree; if they do not, it is an ABO discrepancy that must be investigated.",{"question":79,"answer":80},"Why is reverse grouping necessary if forward grouping already gives the blood group?","Because it is a built-in safety check. Forward and reverse results should mirror each other, and a disagreement flags weak antigens, unexpected antibodies, or rare phenotypes such as Bombay. Reporting a group from forward typing alone can be dangerous.",{"question":82,"answer":83},"What is the Bombay blood group?","A rare phenotype that lacks the H antigen, so the cells carry no A, B, or H antigen. On forward typing it looks like group O, but the serum contains anti-H that agglutinates ordinary O cells. Bombay patients can only receive Bombay blood, so recognizing it is critical.",{"question":85,"answer":86},"Is there a \"d\" antigen in the Rh system?","No. Rh-negative simply means the D antigen is absent. Lowercase \"d\" is only a way of writing \"no D,\" not an antigen that can be detected.",{"question":88,"answer":89},"Why is anti-D not naturally present in Rh-negative people?","Unlike anti-A and anti-B, which occur naturally, anti-D forms only after an Rh-negative person is exposed to Rh-positive red cells, through transfusion or pregnancy. This is why Rh-negative mothers are given anti-D immunoglobulin to prevent sensitization.",{"question":91,"answer":92},"Which blood group is the universal donor?","Group O red cells are the universal red cell donor because they carry no A or B antigen. For plasma, group AB is the universal donor because AB plasma has no anti-A or anti-B. The direction differs for cells versus plasma.",[65],{"slug":95,"title":96,"description":97,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":98,"lastUpdatedDate":73,"draft":42,"category":43,"image":38,"faq":99,"tags":118},"radioimmunoassay-principle-use-limitation","Radioimmunoassay (RIA): The Competitive Principle (More Antigen, Less Signal)","How radioimmunoassay measures tiny amounts of antigen: labeled and unlabeled antigen compete for limited antibody, so the radioactive signal falls as the sample's antigen rises. Principle, procedure, RIA vs ELISA, and limitations.","2020-06-11",[100,103,106,109,112,115],{"question":101,"answer":102},"What is the principle of radioimmunoassay?","RIA is based on competition. A fixed, limited amount of antibody is offered both a fixed amount of radiolabeled antigen and the unknown unlabeled antigen from the sample. The two compete for the antibody, and the amount of labeled antigen that ends up bound is measured as radioactivity.",{"question":104,"answer":105},"Why does more antigen give a lower signal in RIA?","Because the patient's unlabeled antigen competes the labeled antigen away from the limited antibody sites. The more antigen in the sample, the less labeled antigen stays bound, so the bound radioactivity falls. The signal is inversely proportional to the antigen concentration.",{"question":107,"answer":108},"Which radioisotopes are used in RIA?","Most commonly iodine-125, and sometimes tritium (3H). The isotope labels the reagent antigen, and its radioactivity is measured with a gamma or scintillation counter.",{"question":110,"answer":111},"What is the difference between RIA and ELISA?","Both use the same competitive principle, but RIA uses a radioactive label read as radioactivity, while ELISA uses an enzyme label read as a color change. ELISA has replaced RIA in most routine laboratories because it avoids radiation hazard while giving comparable sensitivity.",{"question":113,"answer":114},"What is the difference between RIA and IRMA?","RIA is competitive and uses a labeled antigen, so the signal is inversely proportional to the antigen concentration. IRMA is non-competitive and uses a labeled antibody to sandwich the antigen, so its signal is directly proportional to the antigen concentration.",{"question":116,"answer":117},"Why has RIA been largely replaced?","Because of the hazards and inconvenience of radioactivity: safety precautions, licensing, radioactive waste disposal, and short reagent shelf life. ELISA and other non-radioactive assays match its performance without these problems.",[65],{"slug":120,"title":121,"description":122,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":123,"lastUpdatedDate":73,"draft":42,"category":43,"image":38,"faq":124,"tags":143},"indirect-fluorescent-antibody-ifa-test","Indirect Fluorescent Antibody (IFA) Test: Principle, Procedure, and Uses","How the indirect fluorescent antibody (IFA) test uses two antibodies to detect antibodies in patient serum (and antigens in cells). Principle, procedure, syphilis example, and why the indirect design amplifies the signal.","2020-06-09",[125,128,131,134,137,140],{"question":126,"answer":127},"What does the indirect fluorescent antibody (IFA) test detect?","Most often it detects specific antibodies in a patient's serum or CSF, for example antibodies against the agents of rabies, syphilis, toxoplasmosis, leishmaniasis, or legionellosis. The same two-antibody design can also detect antigens in cells.",{"question":129,"answer":130},"Why does IFA use two antibodies?","A patient's own antibody carries no fluorescent label and cannot be seen. IFA adds a second, labeled antibody directed against human immunoglobulin, which binds the patient's antibody and makes it visible. Because several labeled secondary antibodies bind each primary, the signal is amplified.",{"question":132,"answer":133},"Why is IFA more sensitive than DFA?","In IFA, multiple labeled secondary antibodies stack onto each primary antibody, multiplying the fluorescent signal. The direct method (DFA) uses a single labeled antibody, so its signal is not amplified.",{"question":135,"answer":136},"What is the difference between IFA and FTA-ABS?","FTA-ABS is a specific application of indirect immunofluorescence used to confirm syphilis. It adds an absorption step to remove antibodies that cross-react with non-pathogenic treponemes, improving specificity.",{"question":138,"answer":139},"What colors are seen in an IFA test?","FITC-labeled antibody produces apple-green (sometimes called yellow-green) fluorescence, and rhodamine-labeled antibody produces red. A positive result is the specific glow at the site where antibody has bound.",{"question":141,"answer":142},"Is IFA quantitative?","It is semi-quantitative. By testing serial dilutions of the patient's serum, the laboratory can estimate an antibody titer, which is useful for judging the strength of a response or following it over time.",[65,144],"immunofluorescence",{"slug":146,"title":147,"description":148,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":149,"lastUpdatedDate":41,"draft":42,"category":43,"image":38,"faq":150,"tags":169},"direct-fluorescent-antibody-dfa-test","Direct Fluorescent Antibody (DFA) Test: Principle, Procedure, and Clinical Uses","How the direct fluorescent antibody (DFA) test detects antigen directly in a specimen using one labeled antibody. Principle, step-by-step procedure, apple-green result, and the key clinical uses (rabies, RSV, Legionella, chlamydia)","2019-11-18",[151,154,157,160,163,166],{"question":152,"answer":153},"What does a direct fluorescent antibody (DFA) test detect?","It detects a specific antigen present directly in a specimen, such as a virus or bacterium, using a single antibody that is already labeled with a fluorescent dye. It does not detect antibodies in the patient's blood.",{"question":155,"answer":156},"What does a positive DFA result look like?","Areas where the target antigen is present glow apple-green under a fluorescence microscope. A negative result shows no fluorescence or only faint nonspecific background.",{"question":158,"answer":159},"Why is DFA used for rabies diagnosis?","The rabies virus is difficult to culture, and a rapid answer is critical for public health decisions. DFA detects rabies antigen directly in brain tissue and is the reference (gold-standard) test for post-mortem rabies diagnosis.",{"question":161,"answer":162},"What is the difference between DFA and IFA?","DFA (direct) uses one labeled antibody that binds the antigen in a single step. IFA (indirect) uses an unlabeled primary antibody followed by a labeled secondary antibody, which amplifies the signal. DFA is faster; IFA is generally more sensitive.",{"question":164,"answer":165},"Does DFA need a UV microscope?","No. The common fluorophore FITC is excited by blue light and emits green. A fluorescence microscope with the correct filter set is required, not specifically a UV lamp.",{"question":167,"answer":168},"Why must DFA slides be read promptly?","Fluorescent dyes photobleach, meaning the signal fades with time and light exposure. Slides do not archive well and should be examined soon after staining.",[65,144],{"slug":171,"title":172,"description":173,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":174,"lastUpdatedDate":73,"draft":42,"category":43,"image":38,"faq":175,"tags":194},"coombs-test-types-principle-results","Coombs Test: Direct vs Indirect (DAT vs IAT), and How to Interpret Results","The Coombs (antiglobulin) test explained: why direct detects antibody already on the patient's red cells and indirect detects antibody in serum, what a positive DAT means (warm vs cold AIHA), and where each test is used.","2019-05-04",[176,179,182,185,188,191],{"question":177,"answer":178},"What is the difference between direct and indirect Coombs tests?","The direct test (DAT) checks the patient's red cells for antibody that has already coated them in the body. The indirect test (IAT) checks the patient's serum for antibody that could coat red cells, by first mixing the serum with test cells. Direct tests cells; indirect tests serum.",{"question":180,"answer":181},"What does a positive direct Coombs test mean?","It means the patient's red cells are coated with antibody or complement. Depending on the clinical picture, this points to autoimmune hemolytic anemia, hemolytic disease of the newborn, or a transfusion reaction. A positive result alone does not prove active hemolysis; it must be read with hemolysis markers.",{"question":183,"answer":184},"Why can't incomplete (IgG) antibodies agglutinate red cells on their own?","Red cells carry a negative surface charge that holds them about 20 nm apart, and IgG's binding arms are too short to bridge that distance. The Coombs reagent (antihuman globulin) supplies the bridge, linking IgG-coated cells into visible clumps.",{"question":186,"answer":187},"What is the Coombs reagent made of?","It is antihuman globulin. The polyspecific reagent contains anti-IgG and anti-C3d (a complement fragment). If a test is positive, monospecific anti-IgG and anti-C3d reagents are used to determine exactly what is coating the cells.",{"question":189,"answer":190},"Where is the indirect Coombs test used?","In crossmatching before transfusion, in antibody screening, and in prenatal testing to detect maternal antibodies that could harm the fetus.",{"question":192,"answer":193},"Why must red cells be washed during the test?","Washing removes free, unbound immunoglobulin. If it is left in, it would bind and neutralize the antihuman globulin reagent before it can bridge the cells, producing a false negative.",[65],{"slug":196,"title":197,"description":198,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":199,"lastUpdatedDate":200,"draft":42,"category":43,"image":38,"faq":201,"tags":202},"antibodies-disease-diagnosis","Serological Tests for Disease Diagnosis: A Complete Guide to Antibody Detection","Serological tests detect antibodies or antigens in patient serum to diagnose infections. This hub covers interpretation principles, seroconversion, the 9 key infections diagnosed serologically, all major test methods (ELISA, ICT, HAI, CFT, RIA, IFA), and links to detailed procedure articles for each test.","2019-02-01","2026-07-06",[],[65],{"slug":204,"title":205,"description":206,"seoTitle":207,"seoDescription":208,"author":39,"createdDate":209,"lastUpdatedDate":210,"draft":42,"category":43,"image":38,"faq":211,"tags":236},"widal-test-principle-procedure-results","Widal Test: How to Read Titers Against a Local Baseline (with Nepal Data)","Widal test: principle, slide and tube procedure, result interpretation, diagnostic titers by region, false positives, limitations, and comparison with newer typhoid diagnostic tests. Includes Nepal-specific baseline titer data.","Widal Test: Procedure, Titers, Interpretation, and Limitations","Review Widal test antigen reactions, slide and tube procedures, regional titer interpretation, timing, limitations, and frequent causes of false results.","2015-12-01","2026-07-18",[212,215,218,221,224,227,230,233],{"question":213,"answer":214},"What is the significant titer for a positive Widal test?","No universal threshold — depends on local endemicity. Nepal baseline (Acharya T et al., JHAS 2013): anti-O >1:80, anti-H >1:160. Fourfold rise between acute and convalescent samples is the most reliable criterion.",{"question":216,"answer":217},"What is the difference between O and H agglutination?","O: somatic antigen, compact granular clumps, day 6-8, declines early — marker for active infection. H: flagellar antigen, large fluffy clumps, day 10-12, persists long — may reflect past infection or vaccination.",{"question":219,"answer":220},"Why can the Widal test be falsely positive?","Previous typhoid vaccination, past subclinical infection in endemic areas, cross-reactions with malaria, liver disease, and other Salmonella serotypes all cause false positives.",{"question":222,"answer":223},"Can the Widal test be negative in proven typhoid?","Yes — antibiotics taken before testing, testing too early (before day 6-8), immunocompromised patient, or Vi antigen interference. A negative Widal does not exclude typhoid.",{"question":225,"answer":226},"Why must baseline titers be established locally?","Endemic populations have raised background titers from subclinical exposures. Nepal research (Acharya T et al., JHAS 2013): >1:80 for anti-O and >1:160 for anti-H diagnostically significant based on 490 healthy donors.",{"question":228,"answer":229},"Is the Widal test still recommended?","Widely used in resource-limited settings. Variable sensitivity (47-77%) and specificity (50-92%). Typhidot and Tubex TF offer better specificity. Blood culture is gold standard. Widal useful with clinical judgment and local baseline titers.",{"question":231,"answer":232},"What is the best time to perform the Widal test?","Second week of illness — O antibodies day 6-8, H antibodies day 10-12. First week testing gives false negatives. Paired acute and convalescent samples with fourfold rise is gold standard.",{"question":234,"answer":235},"What does positive AH or BH mean?","AH = Salmonella Paratyphi A flagellar antigen = paratyphoid fever A. BH = Salmonella Paratyphi B = paratyphoid fever B. Cross-reactivity with H antigen can occur.",[65],{"slug":238,"title":239,"description":240,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":241,"lastUpdatedDate":73,"draft":42,"category":43,"image":38,"faq":242,"tags":252},"hemagglutination-inhibition-test-hai-principle-procedure-result-interpretations","Hemagglutination Inhibition Test: Principle, Procedure, Uses","How the hemagglutination inhibition (HAI) test measures antiviral antibodies: antibody blocks the virus from agglutinating red cells, so no clumping means a positive result. Principle, procedure, titer, and interpretation.","2014-12-25",[243,246,249],{"question":244,"answer":245},"Why is no clumping a positive HAI result?","Because the patient's antibody blocks the virus from agglutinating the red cells. If antibody is present, the cells stay unclumped and settle as a button. Clumping means no blocking antibody is present.",{"question":247,"answer":248},"What is the HAI titer?","The highest dilution of serum that still prevents hemagglutination. Beyond that dilution there is too little antibody to block the virus, and clumping returns.",{"question":250,"answer":251},"Why must serum be pretreated before an HAI test?","Serum contains non-specific inhibitors of viral hemagglutination and naturally occurring red-cell agglutinins that can cause false positive or false negative results. Pretreatment removes them so the test measures only specific antibody.",[65],[254,260,266,271,275,279,284,289,293,297],{"slug":255,"name":39,"description":256,"image":257,"body":258,"postCount":259},"acharya-tankeshwar","Editor-in-chief","https:\u002F\u002Fassets.microbeonline.com\u002Fauthors\u002Ftankeshwar-acharya-author-microbeonline.jpg","***Tankeshwar Acharya, MSc (Medical Microbiology)***\n\n*Tankeshwar Acharya is an Assistant Professor in the Department of Microbiology at Patan Academy of Health Sciences (PAHS), Nepal, where he has been teaching and practicing clinical microbiology for over 14 years. He is the founder of Microbe Online, one of the leading free microbiology education resources on the web, covering bacteriology, mycology, parasitology, immunology, and clinical laboratory diagnostics written from direct experience in both the classroom and the diagnostic laboratory.*",432,{"slug":261,"name":71,"description":262,"image":263,"body":264,"postCount":265},"ashma-shrestha","SEO Copywriter and Science Communicator\nKathmandu, Nepal","https:\u002F\u002Fassets.microbeonline.com\u002Fauthors\u002Fashma-shrestha.png","Ashma Shrestha holds a Master of Science in Medical Microbiology from the Institute of Science and Technology (IOST), Tribhuvan University, Nepal, where she developed a strong foundation in virology, molecular biology, and diagnostic microbiology.\n\nShe now works as an SEO Copywriter at Resolution Digital, where she combines her scientific training with research-driven content strategy. She is certified in Google Analytics and Google Business Profile (GBP), and brings a data-informed approach to science communication writing content that is not only accurate but structured to reach and serve the students who need it most.\n\nAt microbeonline, Ashma contributes articles primarily in virology and molecular biology, areas she finds most compelling for their mechanistic depth and their growing clinical relevance. Her writing reflects the same standard the site is built on: factual rigor, clear explanation of the *why* behind microbiology concepts, and content that helps students move from memorization to genuine understanding.\n\nShe is passionate about making complex microbiological concepts accessible without sacrificing accuracy; a skill that sits at the intersection of her scientific training and her professional work in content and SEO.",81,{"slug":267,"name":268,"description":269,"image":38,"body":38,"postCount":270},"sushmita-baniya","Sushmita Baniya","Author \u002F Contributor",32,{"slug":272,"name":273,"description":269,"image":38,"body":38,"postCount":274},"samikshya-acharya","Samikshya Acharya",20,{"slug":276,"name":277,"description":269,"image":38,"body":38,"postCount":278},"alisha-tripathi","Alisha Tripathi",6,{"slug":280,"name":281,"description":282,"image":38,"body":38,"postCount":283},"aastha-shrestha","Aastha Shrestha"," Author \u002F Contributor",10,{"slug":285,"name":286,"description":287,"image":38,"body":38,"postCount":288},"guest-author","Guest Author","Guest Author \u002F Contributor",2,{"slug":290,"name":291,"description":269,"image":38,"body":38,"postCount":292},"srijana-khanal","Srijana Khanal",18,{"slug":294,"name":295,"description":287,"image":38,"body":38,"postCount":296},"dr-poonam-acharya","Dr. Poonam Acharya",1,{"slug":298,"name":299,"description":269,"image":38,"body":300,"postCount":301},"nisha-rijal","Nisha Rijal","**Nisha Rijal** is a microbiologist and quality assurance specialist. She served for nearly 12 years as a microbiologist at the National Public Health Laboratory (NPHL), Nepal's national reference laboratory, and continues to work as a consultant microbiologist in international public health organization. ",51]